A Study of LY3316531 in Healthy Participants

Summary

The purpose of this study is to assess study drug activity by giving LY3316531 or placebo into a vein in the arm and then measuring blood flow of the skin, after capsaicin is applied to skin's surface. The study will last about 16 weeks inclusive of the screening period.

Timeline

Start

2018-08-30

Primary completion

2019-03-15

Completion

2019-03-15

Outcome

Met primary endpoint

registry analysis (superiority test); Placebo vs 300 mg LY3316531; p <0.001; Mean Difference (Final Values) 263.54; t-test, 1 sided NCT03611608 ↗

Drugs

Indications

No indication recorded.